Log in to save to my catalogue

901 Bacillus Calmette-Guerin can subvert patients antitumor immune response by downregulating HLA-I...

901 Bacillus Calmette-Guerin can subvert patients antitumor immune response by downregulating HLA-I...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d262bfe422b04e98b874bffb33a89347

901 Bacillus Calmette-Guerin can subvert patients antitumor immune response by downregulating HLA-I expression on cancer cells

About this item

Full title

901 Bacillus Calmette-Guerin can subvert patients antitumor immune response by downregulating HLA-I expression on cancer cells

Publisher

London: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A945-A945

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

BackgroundPatients with high-risk non muscle-invasive bladder cancer (NMIBC) frequently relapse after standard BCG immunotherapy and have a dismal outcome after progression to muscle-invasive bladder cancer (MIBC).1 2 The mechanisms of tumor resistance to such immunotherapy remain elusive.MethodsWe performed functional assays of fresh human bladder...

Alternative Titles

Full title

901 Bacillus Calmette-Guerin can subvert patients antitumor immune response by downregulating HLA-I expression on cancer cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d262bfe422b04e98b874bffb33a89347

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d262bfe422b04e98b874bffb33a89347

Other Identifiers

E-ISSN

2051-1426

DOI

10.1136/jitc-2021-SITC2021.901

How to access this item